[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioTech Visionary [@BioTechVisions](/creator/twitter/BioTechVisions) on x XX followers Created: 2025-07-23 19:36:21 UTC 🚨 Genentech to Cut XX More Jobs at South San Francisco Campus — Part of Ongoing Restructuring Genentech is launching another round of layoffs at its South San Francisco headquarters, this time eliminating XX jobs across technical and leadership roles—including data scientist-engineers, senior scientists, and business analysts—beginning September 15, 2025, with additional terminations through January 2026. This is part of a broader reshaping of the company: in June, XXX positions were cut, and over XXX jobs have been impacted in total over the past XX months during portfolio reprioritization and the shuttering of the cancer immunology unit. While workforce reductions continue, Roche and Genentech are doubling down on infrastructure investments—including a major campus redevelopment and a $700M manufacturing buildout in North Carolina—signaling a strategic pivot toward future growth areas. 🏢⚙️ #Biotech #Layoffs #Genentech #WorkforceRestructuring #Roche #LifeSciences #SFBiotech  XX engagements  **Related Topics** [chapter 11](/topic/chapter-11) [Post Link](https://x.com/BioTechVisions/status/1948104920974111218)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioTech Visionary @BioTechVisions on x XX followers
Created: 2025-07-23 19:36:21 UTC
🚨 Genentech to Cut XX More Jobs at South San Francisco Campus — Part of Ongoing Restructuring
Genentech is launching another round of layoffs at its South San Francisco headquarters, this time eliminating XX jobs across technical and leadership roles—including data scientist-engineers, senior scientists, and business analysts—beginning September 15, 2025, with additional terminations through January 2026.
This is part of a broader reshaping of the company: in June, XXX positions were cut, and over XXX jobs have been impacted in total over the past XX months during portfolio reprioritization and the shuttering of the cancer immunology unit.
While workforce reductions continue, Roche and Genentech are doubling down on infrastructure investments—including a major campus redevelopment and a $700M manufacturing buildout in North Carolina—signaling a strategic pivot toward future growth areas. 🏢⚙️
#Biotech #Layoffs #Genentech #WorkforceRestructuring #Roche #LifeSciences #SFBiotech
XX engagements
Related Topics chapter 11